Detalhe da pesquisa
1.
Correlation of Baseline Tumor Burden with Clinical Outcome in Melanoma Patients Treated with Ipilimumab.
Oncology
; 102(1): 76-84, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37579734
2.
Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(4): 1089-1099, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113003
3.
Dermatofluoroscopy diagnostics in different pigmented skin lesions: Strengths and weaknesses.
J Dtsch Dermatol Ges
; 18(7): 682-690, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657017
4.
A phase II study of the L19IL2 immunocytokine in combination with dacarbazine in advanced metastatic melanoma patients.
Cancer Immunol Immunother
; 68(9): 1547-1559, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31482307
5.
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
Cancer Immunol Immunother
; 68(5): 765-772, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30806748
6.
Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
J Immunol
; 198(2): 927-936, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27986910
7.
Accurate quantification of T-cells expressing PD-1 in patients on anti-PD-1 immunotherapy.
Cancer Immunol Immunother
; 67(12): 1845-1851, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30218171
8.
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.
Proc Natl Acad Sci U S A
; 112(19): 6140-5, 2015 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25918390
9.
The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma.
Int J Mol Sci
; 19(8)2018 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30103488
10.
Intralesional treatment of metastatic melanoma: a review of therapeutic options.
Cancer Immunol Immunother
; 66(5): 647-656, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28078357
11.
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.
Cancer Immunol Immunother
; 66(4): 441-449, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28008452
12.
High-sensitivity HLA class I peptidome analysis enables a precise definition of peptide motifs and the identification of peptides from cell lines and patients' sera.
Proteomics
; 16(10): 1570-80, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26992070
13.
Phenotypic characterization and prognostic impact of circulating γδ and αß T-cells in metastatic malignant melanoma.
Int J Cancer
; 138(3): 698-704, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383054
14.
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma.
Int J Cancer
; 137(11): 2607-17, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018980
15.
Increased CCL17 serum levels are associated with improved survival in advanced melanoma.
Cancer Immunol Immunother
; 64(9): 1075-82, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25990074
16.
Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.
Ann Surg Oncol
; 22(12): 4073-80, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25712801
17.
Die Dermatofluoroskopie als Diagnoseverfahren bei verschiedenen pigmentierten Hautläsionen: Stärken und Schwächen.
J Dtsch Dermatol Ges
; 18(7): 682-691, 2020 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-32713160
18.
Vemurafenib reverses immunosuppression by myeloid derived suppressor cells.
Int J Cancer
; 133(7): 1653-63, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23526263
19.
Putative Cancer Stem Cell Markers are Frequently Expressed by Melanoma Cells in Vitro and in Situ but are also Present in Benign Differentiated Cells.
Front Biosci (Landmark Ed)
; 28(9): 193, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37796710
20.
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
J Immunother Cancer
; 11(6)2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286306